UBS Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $847K | Sell |
30,616
-19,373
| -39% | -$536K | ﹤0.01% | 4476 |
|
|
2025
Q1 | $1.11M | Sell |
49,989
-8,609
| -15% | -$191K | ﹤0.01% | 4113 |
|
|
2024
Q4 | $1.16M | Buy |
58,598
+9,091
| +18% | +$180K | ﹤0.01% | 4115 |
|
|
2024
Q3 | $1.24M | Buy |
+49,507
| New | +$1.24M | ﹤0.01% | 3420 |
|
|
2024
Q2 | – | Sell |
-104,762
| Closed | -$2.07M | – | 8575 |
|
|
2024
Q1 | $2.07M | Buy |
104,762
+19,346
| +23% | +$382K | ﹤0.01% | 2961 |
|
|
2023
Q4 | $1.5M | Buy |
85,416
+22,602
| +36% | +$396K | ﹤0.01% | 3102 |
|
|
2023
Q3 | $1.09M | Buy |
62,814
+18,171
| +41% | +$316K | ﹤0.01% | 3010 |
|
|
2023
Q2 | $629K | Sell |
44,643
-6,672
| -13% | -$93.9K | ﹤0.01% | 3652 |
|
|
2023
Q1 | $552K | Sell |
51,315
-5,790
| -10% | -$62.3K | ﹤0.01% | 3625 |
|
|
2022
Q4 | $855K | Buy |
+57,105
| New | +$855K | ﹤0.01% | 3268 |
|
|
2022
Q2 | – | Sell |
-1,173
| Closed | -$12K | – | 9494 |
|
|
2022
Q1 | $12K | Sell |
1,173
-75,302
| -98% | -$770K | ﹤0.01% | 7135 |
|
|
2021
Q4 | $900K | Sell |
76,475
-6,262
| -8% | -$73.7K | ﹤0.01% | 3524 |
|
|
2021
Q3 | $942K | Buy |
82,737
+62,718
| +313% | +$714K | ﹤0.01% | 3300 |
|
|
2021
Q2 | $279K | Sell |
20,019
-15,624
| -44% | -$218K | ﹤0.01% | 4124 |
|
|
2021
Q1 | $660K | Buy |
35,643
+34,276
| +2,507% | +$635K | ﹤0.01% | 3713 |
|
|
2020
Q4 | $24K | Sell |
1,367
-1,143
| -46% | -$20.1K | ﹤0.01% | 5795 |
|
|
2020
Q3 | $38K | Sell |
2,510
-8,141
| -76% | -$123K | ﹤0.01% | 4983 |
|
|
2020
Q2 | $271K | Buy |
10,651
+3,441
| +48% | +$87.6K | ﹤0.01% | 3801 |
|
|
2020
Q1 | $112K | Sell |
7,210
-11,758
| -62% | -$183K | ﹤0.01% | 4340 |
|
|
2019
Q4 | $210K | Buy |
18,968
+9,604
| +103% | +$106K | ﹤0.01% | 4570 |
|
|
2019
Q3 | $80K | Buy |
9,364
+7,629
| +440% | +$65.2K | ﹤0.01% | 4974 |
|
|
2019
Q2 | $23K | Buy |
+1,735
| New | +$23K | ﹤0.01% | 5644 |
|
|
2018
Q4 | – | Sell |
-1,530
| Closed | -$39K | – | 7139 |
|
|
2018
Q3 | $39K | Buy |
+1,530
| New | +$39K | ﹤0.01% | 5450 |
|